FDA Approves New Tablet to Reduce Stroke, Heart Attack Risk
The agency approves Zontivity to reduce the risk of heart attack, stroke and cardiovascular death in high risk patients.
Leave a reply →The agency approves Zontivity to reduce the risk of heart attack, stroke and cardiovascular death in high risk patients.
Leave a reply →